As a consequence of hyperactive β-catenin signaling in murine models, tumor cells do not express chemokines such as CCL4 [24] or CCL5 [25], resulting in a reduced or missing recruitment of Batf3-dependent DCs that are required for priming antigen-specific CD8+ T cells [24]. The gene discussed is CD8A; the disease is neoplasm.